Premium
An answer to “anticoagulant treatment of cancer‐associated venous thromboembolism: Interpreting real‐world data with caution”
Author(s) -
Streiff Michael B.,
Milentijevic Dejan,
McCrae Keith,
Yannicelli Daniel,
Lejeune Dominique,
Nelson Winnie W.,
Laliberté François,
Crivera Concetta,
Lefebvre Patrick,
Schein Jeff,
Khorana Alok A.
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25165
Subject(s) - medicine , pairwise comparison , venous thromboembolism , rivaroxaban , warfarin , inverse probability weighting , population , randomized controlled trial , clinical trial , low molecular weight heparin , cancer , intensive care medicine , heparin , statistics , propensity score matching , thrombosis , mathematics , environmental health , atrial fibrillation
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom